:Colesevelam    (DrugBank: Colesevelam)

2 diseases
告示番号疾患名(ページ内リンク)臨床試験数
96クローン病2
260シトステロール血症1

96. クローン病 [臨床試験数:2,209,薬物数:1,276(DrugBank:240),標的遺伝子数:166,標的パスウェイ数:210
Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 2,209 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2009-010727-91-DE01/03/201105/06/2012Colesevelam, which is a medication which binds bile acid, to test in patients with Crohns diseaseColesevelam for the treatment of bile acid malabsorption in patients with Crohn’s disease (Colesevelam für die Therapie der Gallensäuren-Malabsorption bei M. Crohn-Patienten) Morbus Crohn
MedDRA version: 14.1Level: PTClassification code 10011401Term: Crohn's diseaseSystem Organ Class: 10017947 - Gastrointestinal disorders
Trade Name: Cholestagel
Product Name: Cholestagel
Product Code: EU/1/03/268/002
INN or Proposed INN: Colesevelam
LMU München, Campus GroßhadernNULLNot RecruitingFemale: yes
Male: yes
Germany
2NCT01203254October 201015/9/2010Colesevelam for the Treatment of Bile Acid Malabsorption in Patients With Crohn's DiseaseColesevelam for the Treatment of Bile Acid Malabsorption in Patients With Crohn's DiseaseCrohns Disease;Bile Acid MalabsorptionDrug: Colesevelam;Drug: PlaceboFlorian BeigelNULLTerminated18 Years65 YearsBoth34Phase 4Germany

260. シトステロール血症 [臨床試験数:13,薬物数:13(DrugBank:4),標的遺伝子数:1,標的パスウェイ数:1
Searched query = "Sitosterolemia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 13 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01948648February 6, 20186/9/2013Effects of Fish Oil and Colesevelam (STAIR7007)Effects of Fish Oil, Colesevelam and Combination Therapy on Sterol Metabolism in SitosterolemiaSitosterolemiaDrug: Colesevelam;Dietary Supplement: Fish Oil;Drug: Combination of fish oil and colesevelamUniversity of ManitobaNULLActive, not recruiting8 YearsN/AAll13N/ACanada